Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Diagn Histopathol (Oxf). 2013 Sep;19(9):322–330. doi: 10.1016/j.mpdhp.2013.06.015

Table 1. Ways in Which Protected Health Information Can be Used and Disclosed by Covered Entities For Research Under the HIPAA Privacy Rule [45 CFR parts 160, 162, and 164].

  • With individual's authorization for research [See 45 CFR part 164.508]

  • Without individual's authorization if one of the following applies and other conditions in the Rule have been met [See 45 CFR part 164.512]:
    • IRB or Privacy Board waiver
    • Preparatory to research (with certain representations)
    • Limited data set (with data use agreement)
    • De-identified dataset
    • Research solely on decedents
    • Informed consent, waiver of informed consent, or permission before compliance date